New
Drug-Eluting Stents Used
At OSF Saint Anthony Medical Center
First
Procedure Takes Place Four Days After FDA Approval
|

Dr. Michael
L. Hogan
|
Only
four days after the Food and Drug Administration approved the first drug-eluting
stent for angioplasty procedures, Dr. Michael L. Hogan used the new device
at OSF Saint Anthony Medical Center.
The advance is significant because each year 800,000 angioplasty procedures are
performed in the United States to open clogged coronary arteries. Stents are
tiny metal mesh tubes used to push and hold open narrowed arteries. The Cypher
Stent is the first drug-coated stent to earn approval from the Food and Drug
Administration.
"It helps save appropriately selected patients from having to undergo repeat
procedures, which is a real benefit to patients as well as their families and,
in turn, to society,” says Dr. Hogan, a member of Rockford Cardiology Associates
and independent physician with the Regional Heart Institute.
Sirolimus,
the drug coating the Cypher Stent, is a naturally-occurring antibiotic that is
slowly released into surrounding tissue. The drug inhibits scar tissue from developing
and re-clogging the artery, a condition called restenosis. Restenosis is a common
problem that affects between 15 and 30 percent of those who have a stent placed
in a coronary artery. A study sponsored by the manufacturer found it reduced
restenosis by about two-thirds.
Dr. Hogan stresses patients must meet stringent criteria before receiving the
new stent. It has not been approved for use in bypass graft disease, or for placing
inside another stent located in an artery that has narrowed. It is also not indicated
for use in those suffering from an acute heart attack.
"This
is a revolutionary advance in cardiac care,” explains Dr. Robert L. Minor,
Jr., member of Rockford Cardiology Associates and independent physician with
the Regional Heart Institute. “Drug-eluting
stents could reduce the number of coronary surgeries significantly.”
The procedure took place in Rockford's first all-digital cardiac cath lab. In
2002, the physicians of the Regional Heart Institute performed more than 6,400
procedures in the three cath labs at OSF Saint Anthony. The Regional Heart Institute
is the area's leader in providing cardiac and vascular care in the region.
|
|
What
is a stent?
An intraluminal coronary artery stent is a small, self-expanding, stainless
steel mesh tube that is placed within a coronary artery to keep the vessel
open. It may be used during a coronary artery bypass graft surgery to keep
the grafted vessel open, or after balloon angioplasty to prevent reclosure
of the blood vessel, or during other heart or peripheral vascular proceedures.
 |
All
Digital Cath Lab Improves Care
State-of-the-art technology, equipment, and
additional space for people and their loved ones needing care
all add up to one of the most advanced
cardiac catheterization labs in the country, says Dr. Robert L. Minor,
a member of Rockford Cardiology Associates and independent physician with
the Regional Heart Institute.
Opened in the spring of 2002, this $2 million project puts OSF Saint Anthony
at the forefront of the digital technology revolution in cardiac care. “This
new lab makes us one of the best in the United States, not just in the
Rockford area,” says Dr. Minor.
The lab is equipped with the world’s first all digital X-ray cardiovascular
imaging system. Cardiologists use the new system when performing procedures
to view and treat potential coronary artery blockages that could cause
heart attacks or other serious cardiovascular damage. These procedures
include angiograms, angioplasty and cardiac stent revascularization. Better
images can mean better diagnoses and more effective treatments.
Also as part of the project, a patient admissions area with six beds has
been added, allowing short-stay patients who undergo catheterization procedures
to be admitted directly to the cath lab unit, to undergo the procedure
and to recover in the same unit.
The lab is more proof the Regional Heart Institute at OSF Saint Anthony
is on the leading edge of medical care. |

To learn more, call the Regional Heart Institute
at OSF Saint Anthony at (815) 395-5493 or e-mail community.relations@osfhealthcare.org. |
|